MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel , July 11, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or “the Company”) announced Larry Jasinski, Chief Executive Officer, will present virtually at the Emerging Growth Conference at 10:15 am EDT on Wednesday, July 12, 2023.
For investors who are interested in participating, please use the link below to register and receive any conference updates: https://goto.webcasts.com/starthere.jsp?ei=1603282&tp_key=1cd1dcc46a&sti=rwlk
For attendees who are unable to join the event live, an archived webcast will also be made available on EmergingGrowth.com and on the Emerging Growth YouTube Channel, An archived link to the presentation will be available on the Company’s website after the event.
About ReWalk Robotics Ltd.:
ReWalk Robotics Ltd. is a medical device company that designs, develops, and commercializes innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions. ReWalk’s mission is to fundamentally change the quality of life for these individuals through the creation and development of market leading technologies. Founded in 2001, ReWalk has operations in the U.S., Israel, and Germany. For more information on the ReWalk systems, please visit rewalk.com.
ReWalk® and ReStore® are registered trademarks of ReWalk Robotics Ltd. in the United States and other jurisdictions.
ReWalk Investor Contact: Michael Lawless Chief Financial Officer ReWalk Robotics Ltd. E: This email address is being protected from spambots. You need JavaScript enabled to view it. | ReWalk Media Relations: John Tomlin E: This email address is being protected from spambots. You need JavaScript enabled to view it. |
Last Trade: | US$1.80 |
Daily Change: | -0.14 -7.22 |
Daily Volume: | 60,156 |
Market Cap: | US$15.790M |
November 12, 2024 October 24, 2024 September 24, 2024 September 04, 2024 |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB